{
    "organizations": [],
    "uuid": "3808f11fabfc0879590befe938ad10335da527d8",
    "author": "",
    "url": "https://www.reuters.com/article/brief-aradigm-submits-marketing-authoris/brief-aradigm-submits-marketing-authorisation-application-to-ema-for-eu-marketing-approval-of-linhaliq-idUSFWN1QR0FM",
    "ord_in_thread": 0,
    "title": "BRIEF-Aradigm Submits Marketing Authorisation Application To EMA For EU Marketing Approval Of Linhaliq",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 9 (Reuters) - Aradigm Corp:\n* ARADIGM SUBMITS MARKETING AUTHORISATION APPLICATION (MAA) TO EMA FOR EU MARKETING APPROVAL OF LINHALIQ IN NON-CYSTIC FIBROSIS BRONCHIECTASIS Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-09T17:01:00.000+02:00",
    "crawled": "2018-03-09T17:17:21.047+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "aradigm",
        "corp",
        "aradigm",
        "submits",
        "marketing",
        "authorisation",
        "application",
        "maa",
        "ema",
        "eu",
        "marketing",
        "approval",
        "linhaliq",
        "fibrosis",
        "bronchiectasis",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}